Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Biotech

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 26, 2021 1:32am

102 Views

Post# 33265908

RE:Biotech

Wow. Laughable. I'm glad you did your due diligence.

hoffbag wrote: What is your reference material on the second injection in the portal vein? Nothing in the trial refers to portal vein injection and in fact the study is to prove safety, tolerability and efficacy of the cell pouch for islet transplantation. Following up with a portal vein injection would make the results meaningless.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing